Robert Paul Hasserjian, MD
Associate Pathologist, Massachusetts General Hospital
Director, Hematopathology Fellowship Program, Pathology Service
Associate Professor of Pathology, Harvard Medical School
Dr. Hasserjian works closely with oncologists and other hematologists to provide optimal patient care. He lectures regularly at continuing medical education courses at medical schools throughout the United States.
- Department of Pathology
- Clinical Interests
- Gastrointestinal (GI) pathology
- Boston: Massachusetts General Hospital
- Medical Education
- MD, Harvard Medical School
- Residency, Brigham and Women's Hospital
- Fellowship, Brigham and Women's Hospital
- Board Certifications
- Anatomic Pathology, American Board of Pathology
- Hematology, American Board of Pathology
- Foreign Languages
- Patient Age Group
- Adult and pediatric
- Accepting New Patients
- Insurances Accepted
- Aetna Health Inc.
Blue Cross Blue Shield - Blue Care 65
Blue Cross Blue Shield - Indemnity
Blue Cross Blue Shield - Managed Care
Blue Cross Blue Shield - Partners Plus
Cigna (PAL #'s)
Fallon Community HealthCare
Great-West Healthcare (formally One Health Plan)
Harvard Pilgrim Health Plan - PBO
Health Care Value Management (HCVM)
Humana/Choice Care PPO
Medicare - ACD
Neighborhood Health Plan - ACD
Neighborhood Health Plan - PBO
OSW - Maine
OSW - Rhode Island
Private Health Care Systems (PHCS)
Railroad Medicare - ACD
Senior Whole Health
Tufts Health Plan
United Healthcare (non-HMO) - ACD
United Healthcare (non-HMO) - PBO
Dr. Hasserjian's clinical work and research focus on myeloid neoplasia. He has served on the Executive Committee of the Society for Hematopathology and on the Education Committee of the United States and Canadian Academy of Pathology. Dr. Hasserjian is a member of the Pathology Advisory Committee for the World Health Organization Classification of Myeloid Neoplasms. Dr. Hasserjian is a dedicated medical educator, and director of the Hematopathology Fellowship at Massachusetts General Hospital.
Dr. Hasserjian's research interests include:
- Molecular mechanisms of leukemia and lymphoma.
- Novel pathologic, immunophenotypic, and molecular prognostic markers in myelodysplastic and myeloproliferative diseases, leukemias, and lymphomas
For more information about research concepts, co-authors, and to see a timeline, visit Dr. Hasserjian?s profile at the Harvard Clinical and Translational Science Center.
View my most recent publications at PubMed
- Chronic lymphocytic leukemia/small lymphocytic lymphoma: another neoplasm related to the B-cell follicle? Tandon B, Swerdlow SH, Hasserjian RP, Surti U, Gibson SE.Leuk Lymphoma. 2015 Apr 10:1-33. [Epub ahead of print]
- Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information. Nardi V, Pulluqi O, Abramson JS, Dal Cin P, Hasserjian RP. Am J Hematol. 2015 Mar 16.[Epub ahead of print]
- Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era? Tamari R, Mughal TI, Rondelli D, Hasserjian R, Gupta V, Odenike O, Fauble V, Finazzi G, Pane F, Mascarenhas J, Prchal J, Giralt S, Hoffman R. Bone Marrow Transplant. 2015 Feb 9. doi: 10.1038/bmt.2014.323. [Epub ahead of print]
55 Fruit Street
Boston, MA 02114-2696
Call the Massachusetts General Hospital physician referral service at 800-711-4644.
Mass General accepts most health insurance plans. Find out what you need to know before coming to Mass General.
Driving to Mass General? Get driving directions or locate a parking lot on the hospital's main campus.